Income Tax Expense (Benefit) in USD of Medpace Holdings, Inc. from Q3 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Medpace Holdings, Inc. quarterly/annual Income Tax Expense (Benefit) history and change rate from Q3 2015 to Q3 2025.
  • Medpace Holdings, Inc. Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $31.7M, a 41.8% increase year-over-year.
  • Medpace Holdings, Inc. Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $86.4M, a 28.8% increase year-over-year.
  • Medpace Holdings, Inc. annual Income Tax Expense (Benefit) for 2024 was $71.5M, a 35.3% increase from 2023.
  • Medpace Holdings, Inc. annual Income Tax Expense (Benefit) for 2023 was $52.9M, a 41% increase from 2022.
  • Medpace Holdings, Inc. annual Income Tax Expense (Benefit) for 2022 was $37.5M, a 87.4% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Medpace Holdings, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $86.4M $31.7M +$9.35M +41.8% 01 Jul 2025 30 Sep 2025 10-Q 23 Oct 2025
Q2 2025 $77.1M $34.3M +$12.1M +54.9% 01 Apr 2025 30 Jun 2025 10-Q 22 Jul 2025
Q1 2025 $64.9M $3.58M -$6.62M -64.9% 01 Jan 2025 31 Mar 2025 10-Q 22 Apr 2025
Q4 2024 $71.5M $16.9M +$4.46M +35.9% 01 Oct 2024 31 Dec 2024 10-K 11 Feb 2025
Q3 2024 $67.1M $22.4M +$9.7M +76.7% 01 Jul 2024 30 Sep 2024 10-Q 23 Oct 2025
Q2 2024 $57.4M $22.1M +$7.46M +50.8% 01 Apr 2024 30 Jun 2024 10-Q 22 Jul 2025
Q1 2024 $49.9M $10.2M -$2.95M -22.4% 01 Jan 2024 31 Mar 2024 10-Q 22 Apr 2025
Q4 2023 $52.9M $12.4M +$7.43M +149% 01 Oct 2023 31 Dec 2023 10-K 11 Feb 2025
Q3 2023 $45.4M $12.7M -$3.21M -20.3% 01 Jul 2023 30 Sep 2023 10-Q 22 Oct 2024
Q2 2023 $48.7M $14.7M +$2.04M +16.1% 01 Apr 2023 30 Jun 2023 10-Q 23 Jul 2024
Q1 2023 $46.6M $13.1M +$9.12M +227% 01 Jan 2023 31 Mar 2023 10-Q 23 Apr 2024
Q4 2022 $37.5M $4.98M -$912K -15.5% 01 Oct 2022 31 Dec 2022 10-K 11 Feb 2025
Q3 2022 $38.4M $15.9M +$9.7M +157% 01 Jul 2022 30 Sep 2022 10-Q 24 Oct 2023
Q2 2022 $28.7M $12.6M +$9.89M +359% 01 Apr 2022 30 Jun 2022 10-Q 25 Jul 2023
Q1 2022 $18.8M $4.01M -$1.19M -22.9% 01 Jan 2022 31 Mar 2022 10-Q 25 Apr 2023
Q4 2021 $20M $5.89M +$2.05M +53.5% 01 Oct 2021 31 Dec 2021 10-K 13 Feb 2024
Q3 2021 $18M $6.16M +$632K +11.4% 01 Jul 2021 30 Sep 2021 10-Q 25 Oct 2022
Q2 2021 $17.3M $2.75M -$3.51M -56% 01 Apr 2021 30 Jun 2021 10-Q 26 Jul 2022
Q1 2021 $20.8M $5.2M -$2.32M -30.8% 01 Jan 2021 31 Mar 2021 10-Q 26 Apr 2022
Q4 2020 $23.1M $3.84M -$2.57M -40.1% 01 Oct 2020 31 Dec 2020 10-K 14 Feb 2023
Q3 2020 $25.7M $5.53M +$42K +0.77% 01 Jul 2020 30 Sep 2020 10-Q 26 Oct 2021
Q2 2020 $25.7M $6.26M -$779K -11.1% 01 Apr 2020 30 Jun 2020 10-Q 27 Jul 2021
Q1 2020 $26.5M $7.52M +$2.06M +37.8% 01 Jan 2020 31 Mar 2020 10-Q 27 Apr 2021
Q4 2019 $24.4M $6.4M -$155K -2.36% 01 Oct 2019 31 Dec 2019 10-K 15 Feb 2022
Q3 2019 $24.5M $5.49M -$666K -10.8% 01 Jul 2019 30 Sep 2019 10-Q 27 Oct 2020
Q2 2019 $25.2M $7.04M +$2.09M +42.2% 01 Apr 2019 30 Jun 2019 10-Q 28 Jul 2020
Q1 2019 $23.1M $5.46M +$2.35M +75.8% 01 Jan 2019 31 Mar 2019 10-Q 29 Apr 2020
Q4 2018 $20.8M $6.56M +$4.18M +175% 01 Oct 2018 31 Dec 2018 10-K 16 Feb 2021
Q3 2018 $16.6M $6.15M +$838K +15.8% 01 Jul 2018 30 Sep 2018 10-Q 29 Oct 2019
Q2 2018 $15.8M $4.95M +$154K +3.21% 01 Apr 2018 30 Jun 2018 10-Q 30 Jul 2019
Q1 2018 $15.6M $3.11M -$2.23M -41.7% 01 Jan 2018 31 Mar 2018 10-Q 30 Apr 2019
Q4 2017 $17.8M $2.38M +$2.14M +865% 01 Oct 2017 31 Dec 2017 10-K 25 Feb 2020
Q3 2017 $15.7M $5.32M +$2.77M +109% 01 Jul 2017 30 Sep 2017 10-Q 30 Oct 2018
Q2 2017 $12.9M $4.79M +$1.57M +48.6% 01 Apr 2017 30 Jun 2017 10-Q 31 Jul 2018
Q1 2017 $11.4M $5.33M +$2.82M +112% 01 Jan 2017 31 Mar 2017 10-Q 01 May 2018
Q4 2016 $8.53M $247K 01 Oct 2016 31 Dec 2016 10-K 26 Feb 2019
Q3 2016 $2.55M +$1.91M +297% 01 Jul 2016 30 Sep 2016 10-Q 31 Oct 2017
Q2 2016 $3.23M 01 Apr 2016 30 Jun 2016 10-Q 01 Aug 2017
Q1 2016 $2.51M 01 Jan 2016 31 Mar 2016 10-Q 02 May 2017
Q3 2015 $641K 01 Jul 2015 30 Sep 2015 10-Q 03 Nov 2016

Medpace Holdings, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $71.5M +$18.7M +35.3% 01 Jan 2024 31 Dec 2024 10-K 11 Feb 2025
2023 $52.9M +$15.4M +41% 01 Jan 2023 31 Dec 2023 10-K 11 Feb 2025
2022 $37.5M +$17.5M +87.4% 01 Jan 2022 31 Dec 2022 10-K 11 Feb 2025
2021 $20M -$3.14M -13.6% 01 Jan 2021 31 Dec 2021 10-K 13 Feb 2024
2020 $23.1M -$1.24M -5.09% 01 Jan 2020 31 Dec 2020 10-K 14 Feb 2023
2019 $24.4M +$3.62M +17.4% 01 Jan 2019 31 Dec 2019 10-K 15 Feb 2022
2018 $20.8M +$2.94M +16.5% 01 Jan 2018 31 Dec 2018 10-K 16 Feb 2021
2017 $17.8M +$9.29M +109% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020
2016 $8.53M +$7.69M +912% 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2019
2015 $843K 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.